Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/214.01
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is seven-membered consisting of one nitrogen and six carbons > Polycyclo ring system having the seven-membered hetero ring as one of the cyclos > Ring nitrogen of the seven-membered hetero ring is shared by an additional cyclo of the polycyclo ring system
Description: Subject matter wherein the ring nitrogen of the seven-membered hetero ring is also a member of an additional cyclo of the polycyclo ring system.










Sub-classes under this class:

Class Number Class Name Patents
514/214.02 Plural ring nitrogens in the polycyclo ring system 150
514/214.03 Two of the cyclos share at least three ring members (i.e., bridged) 142


Patents under this class:
1 2 3

Patent Number Title Of Patent Date Issued
8575152 Non-steroidal compounds useful as glucocorticoid receptor modulators Nov. 5, 2013
8466142 Cephalotaxus esters, methods of synthesis, and uses thereof Jun. 18, 2013
8440649 Phenanthroindolizidine analogues May. 14, 2013
8372830 Methods for using vasopressin antagonists with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival Feb. 12, 2013
8178523 Compounds for the treatment of hepatitis C May. 15, 2012
8143243 Compounds for the treatment of hepatitis C Mar. 27, 2012
8143244 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Mar. 27, 2012
8138171 Dioxolane and dioxolanone fused indolobenzadiazepine HCV NS5B inhibitors Mar. 20, 2012
8138170 Immunosuppressive Ningalin compounds Mar. 20, 2012
8133884 Compounds for the treatment of hepatitis C Mar. 13, 2012
8129367 Compounds for the treatment of Hepatitis C Mar. 6, 2012
8124601 Compounds for the treatment of Hepatitis C Feb. 28, 2012
8039460 CGRP receptor antagonists Oct. 18, 2011
7867998 Method of making antitussive medicine and relieving cough Jan. 11, 2011
7858114 Percutaneous absorption preparations of antidementia drugs Dec. 28, 2010
7842687 Cephalotaxane derivatives and their processes of preparation and purification Nov. 30, 2010
7790712 Substituted [1,4]diazepino[1,2-A]indoles and azepino[1,2-A]indoles as anti-cytokine inhibitors Sep. 7, 2010
7683050 Formulations and methods of administration of cephalotaxines, including homoharringtonine Mar. 23, 2010
7662809 Tetracyclic indole derivatives as antiviral agents Feb. 16, 2010
7652004 Compounds for the treatment of hepatitis C Jan. 26, 2010
7642251 Compounds for the treatment of hepatitis C Jan. 5, 2010
7547690 Compounds for the treatment of Hepatitis C Jun. 16, 2009
7541352 Compounds for the treatment of hepatitis C Jun. 2, 2009
7541351 Compounds for the treatment of hepatitis C Jun. 2, 2009
7541353 Compounds for the treatment of hepatitis C Jun. 2, 2009
7538102 Compounds for the treatment of Hepatitis C May. 26, 2009
7538103 Compounds for the treatment of hepatitis C May. 26, 2009
7521441 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Apr. 21, 2009
7521444 Compounds for the treatment of hepatitis C Apr. 21, 2009
7521443 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Apr. 21, 2009
7521442 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Apr. 21, 2009
7517872 Compounds for the treatment of hepatitis C Apr. 14, 2009
7485633 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Feb. 3, 2009
7473688 Indolobenzazepine HCV NS5B inhibitors Jan. 6, 2009
7465721 2-hydroxytetrahydrofuran derivatives and use thereof as medicaments Dec. 16, 2008
7456165 HCV NS5B inhibitors Nov. 25, 2008
7456166 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Nov. 25, 2008
7456167 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Nov. 25, 2008
7452876 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Nov. 18, 2008
7399758 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors Jul. 15, 2008
7384933 Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments Jun. 10, 2008
7285546 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents Oct. 23, 2007
7250409 Ningalin B analogs employable for reversing multidrug resistance Jul. 31, 2007
7232835 3,6-Disubstituted azabicyclo derivatives as muscarinic receptor antagonists Jun. 19, 2007
7220737 Noribogaine in the treatment of pain and drug addiction May. 22, 2007
7169774 Cephalotaxane derivatives and their processes of preparation and purification Jan. 30, 2007
7153848 Inhibitors of HCV replication Dec. 26, 2006
7141562 Substituted benzoxazinones and uses thereof Nov. 28, 2006
7022729 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists Apr. 4, 2006
6992078 Plant extracts and alkaloids having antitussive activity Jan. 31, 2006

1 2 3










 
 
  Recently Added Patents
Dimmable LED light fixture having adjustable color temperature
System and method for a TCP mapper
Scalable header extension
Watch chain
Vehicle, toy, and/or replicas thereof
Management of computer-file sharing between at least two devices
Pulsed plasma with low wafer temperature for ultra thin layer etches
  Randomly Featured Patents
Method for perforating nonwoven fabric
Tire for automobile
Protective bar assembly for motorcycle
Compact padding machine
Colorimetric circuit with storage of simultaneously detected color components
Magnetic flowmeter
Systems and methods for identifying payor location based on transaction data
Holder
Display device and display driving method therefor
Saddle seat type electric vehicle